• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN (MEDFORD) SERI SURGICAL SCAFFOLD (US); MESH, SURGICAL, ABSORBABLE, PLASTIC AND RECONSTRUCTIVE SURGERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN (MEDFORD) SERI SURGICAL SCAFFOLD (US); MESH, SURGICAL, ABSORBABLE, PLASTIC AND RECONSTRUCTIVE SURGERY Back to Search Results
Catalog Number SCF10X25AGEN
Device Problems Use of Device Problem (1670); Appropriate Term/Code Not Available (3191)
Patient Problem Patient Problem/Medical Problem (2688)
Event Date 07/27/2015
Event Type  Injury  
Manufacturer Narrative
Medwatch sent to fda on 8/20/2015.The event of inadequate tissue ingrowth is a physiological complication, and analysis of the device generally does not assist allergan in determining a probable cause for this event.The physician discarded the device when it was explanted, and it is no longer available for return.Therefore, allergan will not receive the device, and no analysis or testing will be done.Device labeling addresses the reported event of inadequate tissue ingrowth as follows: "seri surgical scaffold must be placed in maximum possible contact with healthy well-vascularized tissue to encourage ingrowth and tissue remodeling." these events are being reported because medical intervention was required, although device-relatedness has not been established.
 
Event Description
Healthcare professional reported implantation of seri surgical scaffold on (b)(6) 2015 during revision to left side mastectomy reconstruction.On (b)(6) 2015, during a cosmetic revision procedure, the device was discovered to be "100% unincorporated" and removed.The healthcare professional believes insufficient vascularization in the patient tissue after the reconstruction may have contributed to the lack of device incorporation, and the unincorporated scaffold device may have contributed to rupture of the breast implant.Both devices were removed on (b)(6) 2015, and the explanted scaffold was discarded after removal.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SERI SURGICAL SCAFFOLD (US)
Type of Device
MESH, SURGICAL, ABSORBABLE, PLASTIC AND RECONSTRUCTIVE SURGERY
Manufacturer (Section D)
ALLERGAN (MEDFORD)
200 boston avenue
medford MA 02155
Manufacturer (Section G)
ALLERGAN (MEDFORD)
200 boston avenue
medford MA 02155
Manufacturer Contact
krista alvarado
301 w howard lane
suite 100
austin, TX 78753
5128132638
MDR Report Key5021064
MDR Text Key23696772
Report Number8020862-2015-00001
Device Sequence Number1
Product Code OXF
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K123128
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Physician
Report Date 07/28/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/21/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/31/2017
Device Catalogue NumberSCF10X25AGEN
Device Lot NumberP14091601A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/28/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/01/2014
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
STYLE 15-421 BREAST IMPLANT
Patient Outcome(s) Required Intervention;
Patient Age66 YR
-
-